1. OncoMyx Therapeutics completes $25M Series A financing - Read Article

    OncoMyx Therapeutics completes $25M Series A financing

    June 5, 2019
  2. Private equity firm buys Phoenix-based Axolotl Biologix - Read Article

    Private equity firm buys Phoenix-based Axolotl Biologix

    May 8, 2019
  3. $10 million gift will build first-of-its-kind X-ray facility at ASU - Read Article

    $10 million gift will build first-of-its-kind X-ray facility at ASU

    April 18, 2019
  4. TGen and HonorHealth contribute to Nature study - Read Article

    TGen and HonorHealth contribute to Nature study

    April 17, 2019
  5. TGen finds gene associated with most common liver cancer - Read Article

    TGen finds gene associated with most common liver cancer

    April 7, 2019
  6. UA immunobiologist will explore copper’s potential as antibiotic - Read Article

    UA immunobiologist will explore copper’s potential as antibiotic

    March 31, 2019
    Oak Flat copper mine
  7. $6.1M in grants pave way for TGen-led studies of deadly lung diseases - Read Article

    $6.1M in grants pave way for TGen-led studies of deadly lung diseases

    March 27, 2019
  8. ASU receives $50M gift in support of dementia research, education - Read Article

    ASU receives $50M gift in support of dementia research, education

    March 25, 2019
    ASU BIODESIGN INSTITUTE
  9. TGen develops program that lights up cancer-causing mutations - Read Article

    TGen develops program that lights up cancer-causing mutations

    March 20, 2019
    VisionGate
  10. TGen plays key role in pancreatic cancer breakthrough - Read Article

    TGen plays key role in pancreatic cancer breakthrough

    March 4, 2019
  11. Scottsdale-based PathogenDx expands staff and footprint - Read Article

    Scottsdale-based PathogenDx expands staff and footprint

    February 25, 2019
  12. Flinn Foundation names new leaders Bioscience Roadmap committee - Read Article

    Flinn Foundation names new leaders Bioscience Roadmap committee

    February 13, 2019
  1. 5
  2. 6
  3. 7
  4. 8
  5. 9